It's super weird to me that the @NateSilver538-@mattyglesias-@zeynep single-doser axis is also the simple age-based prioritization axis.
Because even if single-dosing were partially effective, it would be least effective in the elderly.
-
-
nice touch of sarcasm - so dual-dose for ~122M people, ~240M doses (Ages 65+, medical workers, people with high risk comorbidity) & study ability to do single dose, for healthy frontline workers, saving maybe? 50M doses
-
it occurs to me you thought I was accusing you of recommending single-dosing the elderly -- I was pointing out that if you recommend age-based prioritization, the cohort you'd single/delayed dose is way down the list, so you don't meaningfully extend supply
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.